U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07897032) titled 'Levetiracetam as an Adjuvant Therapy to Hypothermia in Neonatal Asphyxia' on July 24.
Brief Summary: Clinical evaluation of the possible neuroprotective effect of early prophylactic high dose of Levetiracetam as adjunctive therapy to WBC in neonates with HIE.
Study Start Date: Nov. 01
Study Type: INTERVENTIONAL
Condition:
Hypoxic Ischemic Encephalopathy of Newborn
Neuro-protection
Intervention:
DRUG: Levetiracetam
prophylactic LVT using a dose of 60 mg per kilogram followed by eight maintenance doses 15mg /kg every 8 hours will be administered intravenously over a fixed time of 15 min through a central or peripheral line for ...